We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > obesity drug

News List

Could a once-abandoned obesity drug be revived in osteoporosis? fiercebiotech
December 26, 2018
Irisin, the once much-hyped but controversial “exercise hormone” that researchers had hoped would be an effective obesity treatment, could make a comeback—this time in bone strengthening.
Lured by high demand, Korean wholesaler smuggled Novo’s obesity drug Saxenda into China fiercepharma
November 15, 2018
Anti-obesity drug Saxenda has been one of Novo Nordisk’s key growth drivers lately—and apparently, a Korean wholesaler noticed. The pharmaceutical middleman allegedly smuggled the popular drug into China, where it’s not yet approved.
Longer-term results back Rhythm’s ultrarare obesity drug fiercebiotech
May 16, 2018
Rhythm Pharma has additional data for its first-in-class obesity therapy setmelanotide—published in the prestigious journal Nature Medicine—showing that the drug’s effects can extend for over a year.